
Sign up to save your podcasts
Or


Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.
By John Simboli5
77 ratings
Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.

3,072 Listeners

1,993 Listeners

1,105 Listeners

2,342 Listeners

943 Listeners

797 Listeners

125 Listeners

337 Listeners

6,097 Listeners

95 Listeners

10,254 Listeners

551 Listeners

152 Listeners

248 Listeners

187 Listeners